<unk>  monotherapy is indicated in the European Union for the treatment of iron overload in those with thalassaemia major when current chelation therapy is contraindicated or inadequate.<unk>  in combination with another chelator is indicated in the European Union in those with thalassaemia major when monotherapy with any iron chelator is ineffective, or when prevention or treatment of life-threatening consequences of iron overload (mainly cardiac overload) justifies rapid or intensive correction.
Deferiprone
Deferasirox
Gadobenic acid
Deferoxamine
Aquamid
Iron sucrose
Penicilloic acid
Zinc pyrithione